My Cart

Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CEB-Y29c-100ug
$355.00
CEB-Y29c-1mg (500ug X 2)
$2695.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Source

    Anti-Cetuximab Antibody (12B1E9) is a recombinant mouse monoclonal antibody expressed in HEK293 cells.

  • Antibody Type

    Recombinant Monoclonal

  • Clone

    12B1E9

  • Isotype

    Mouse IgG1, Kappa

  • Host Species

    Mouse

  • Immunogen

    Cetuximab

  • Specificity

    Recognizes Cetuximab specifically.

  • Application

    Application
    Recommended Usage
    ELISA
    1:2000-1:20000
  • Purification

    Protein A purified / Protein G purified.

  • Aggregation

    Less than 10%, as determined by SEC-MALS.

  • Concentration

    Please refer to the Certificate of Analysis (CoA).

  • Form

    Lyophilized

  • Formulation

    Lyophilized from a 0.22 μm-filtered solution in Tris (pH 7.5) containing 100 mM Glycine, 25 mM Arginine and 150 mM NaCl, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Reconstitution

    Please refer to the Certificate of Analysis (CoA) for specific instructions.

  • Shipping

    Lyophilized product is shipped at ambient temperature.

  • Storage

    For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     Cetuximab ELISA

    Immobilized Cetuximab at 1 μg/mL (100 μL/well) can bind Anti-Cetuximab Antibody (12B1E9) (Cat. No. CEB-Y29c) with a linear range of 0.2-1.6 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background